Capital Genomix

Capital Genomix possesses two proprietary technology platforms for the comprehensive analysis of genes and proteins. We are pursuing a strategy that will combine the two platforms to identify genes and protein targets for life science research applications ranging from basic research to drug discovery to molecular diagnostics. Below, we provide an introduction to our two technology platforms, GeneSystem320TM and ImmunoMouse™.

Contact Details: 2 Cessna Court Gaithersburg MD 20879 United States of America Tel: 240-401-2801 Fax: 301-948-9442 Email: info@capitalgenomix.com WWW: www.capitalgenomix.com/

Loading...

BioNews Results for Capital Genomix:
Research and Markets: Drug Discovery Technologies - A Global Update of Market Trends & Opportunities	SmartBrief:  Nov 19 2009 2:58AM Matching: capital genomix
Research and Markets: Drug Discovery Technologies - A Global Update of Market Trends & Opportunities	Forbes.com:  Nov 18 2009 3:32PM Matching: capital genomix
Research and Markets: Drug Discovery Technologies - A Global Update of Market Trends & Opportunities	Business Wire UK:  Nov 18 2009 3:12PM Matching: capital genomix

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 277 times since April 2007, the link to the organisation's website has been followed 62 times

Recent Search Terms used to find this page: CAPITAL GENOMIX | .

Search for more companies in Gaithersburg

Search for more companies in MD

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Capital Genomix